Below we review the key evidence: Early Clinical Trials (Intranasal Bremelanotide) Initial studies of PT-141 in men utilized an intranasal spray formulation
References Philippou, A., Maridaki, M., Halapas, A., & Koutsilieris, M
Chronic stress elevates cortisol, which promotes fat storage (especially visceral belly fat) and interferes with fat loss even when youre in a calorie deficit
The nasal spray formulation provides a standardized research format that supports consistency across experimental protocols and facilitates administration within research settings
The SELECT trial (N=17,604), published in the New England Journal of Medicine in 2023, showed that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in overweight or obese adults without diabetes over a median follow-up of 34.2 months
This allows for higher concentrations of nutrients and ensures optimal absorption, especially for those with compromised gut health